OTC Markets OTCPK - Delayed Quote USD
AVITA Medical, Inc. (AVHHL)
1.4200
+0.2700
+(23.48%)
At close: June 5 at 8:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
6/30/2021
Total Revenue
71,661
64,251
50,143
34,421
29,232
Cost of Revenue
10,414
9,094
7,780
6,041
5,949
Gross Profit
61,247
55,157
42,363
28,380
23,283
Operating Expense
112,461
111,750
85,018
55,885
49,823
Operating Income
-51,214
-56,593
-42,655
-27,505
-26,540
Net Non Operating Interest Income Expense
-5,238
-5,361
-1,143
-16
-22
Other Income Expense
-562
163
8,483
892
17
Pretax Income
-57,014
-61,791
-35,315
-26,629
-26,545
Tax Provision
32
54
66
36
38
Net Income Common Stockholders
-57,046
-61,845
-35,381
-26,665
-26,583
Diluted NI Available to Com Stockholders
-57,046
-61,845
-35,381
-26,665
-26,583
Basic EPS
-0.44
-0.48
-0.28
-0.21
-0.23
Diluted EPS
-0.44
-0.48
-0.28
-0.21
-0.23
Basic Average Shares
130,185.0080
129,415.2800
126,656.3200
125,000.9000
113,371.5650
Diluted Average Shares
130,185.0080
129,415.2800
126,656.3200
125,000.9000
113,371.5650
Total Operating Income as Reported
-51,214
-56,593
-42,655
-27,505
-26,540
Total Expenses
122,875
120,844
92,798
61,926
55,772
Net Income from Continuing & Discontinued Operation
-57,046
-61,845
-35,381
-26,665
-26,583
Normalized Income
-57,046
-61,845
-35,381
-26,665
-26,583
Interest Expense
5,238
5,361
1,143
16
22
Net Interest Income
-5,238
-5,361
-1,143
-16
-22
EBIT
-51,776
-56,430
-34,172
-26,613
-26,523
EBITDA
-50,332
-55,304
-33,540
-26,045
-25,808
Reconciled Cost of Revenue
10,414
9,094
7,780
6,041
5,949
Reconciled Depreciation
1,444
1,126
632
568
715
Net Income from Continuing Operation Net Minority Interest
-57,046
-61,845
-35,381
-26,665
-26,583
Normalized EBITDA
-50,332
-55,304
-33,540
-26,045
-25,808
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 9/4/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade